CollPlant Biotechnologies (CLGN) Cash from Operations Growth (3y) (2021 - 2025)
CollPlant Biotechnologies (CLGN) Cash from Operations Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -0.27% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 16.85% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 52.90% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 96.08% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -24.76% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.23% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 6.22% |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.16% |
| Sep 30, 2025 | 3.33% |
| Jun 30, 2025 | 14.87% |
| Dec 31, 2024 | -12.70% |
| Sep 30, 2024 | -6.97% |
| Jun 30, 2024 | -5.14% |
| Mar 31, 2024 | -31.86% |
| Dec 31, 2023 | 19.23% |
| Sep 30, 2023 | 87.11% |
| Jun 30, 2023 | -60.44% |
| Mar 31, 2023 | -49.40% |
| Dec 31, 2022 | -102.94% |
| Sep 30, 2022 | -33.49% |
| Jun 30, 2022 | -30.83% |
| Mar 31, 2022 | -49.62% |
| Dec 31, 2021 | -40.20% |
| Sep 30, 2021 | -37.53% |
| Jun 30, 2021 | -21.55% |
| Mar 31, 2021 | 112.91% |